Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-5-24
|
pubmed:abstractText |
It has been suggested that tumor necrosis factor alpha (TNF alpha) may serve as an important antigen-independent host defense mechanism against parasitic organisms. Sera from 66 patients with leishmaniasis and 68 patients with leprosy, all from Ethiopia, were tested for TNF alpha using an enzyme-linked immunoassay. Sera from patients with the multi-parasitic/bacillary type of disease (visceral or diffuse cutaneous leishmaniasis and lepromatous leprosy), known to be associated with absent or low specific T cell response, contained significantly higher TNF alpha titers than those of patients with pauci-parasitic/bacillary disease (localized cutaneous leishmaniasis and nonlepromatous leprosy). High titers of TNF alpha in the absence of a functioning T cell response do not appear to confer resistance against Leishmania aethiopica and Mycobacterium leprae.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
161
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
988-91
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2324549-Adolescent,
pubmed-meshheading:2324549-Adult,
pubmed-meshheading:2324549-Female,
pubmed-meshheading:2324549-Humans,
pubmed-meshheading:2324549-Immunity, Cellular,
pubmed-meshheading:2324549-Leishmaniasis,
pubmed-meshheading:2324549-Leishmaniasis, Visceral,
pubmed-meshheading:2324549-Leprosy,
pubmed-meshheading:2324549-Leprosy, Borderline,
pubmed-meshheading:2324549-Leprosy, Lepromatous,
pubmed-meshheading:2324549-Male,
pubmed-meshheading:2324549-Middle Aged,
pubmed-meshheading:2324549-Tumor Necrosis Factor-alpha
|
pubmed:year |
1990
|
pubmed:articleTitle |
Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.
|
pubmed:affiliation |
Department of Immunology, Karolinska Institute, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|